Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 
Earnings Analysis: 
Jones Soda Profit More than Triples
Author: 123jump.com Staff
123jump.com
Last Update: 12:44 PM EST March 09 2007



Email article | Print article

Lumera widens its fourth-quarter losses on higher revenue. AeroVironment third-quarter earnings almost doubled, mainly due to strong demand for its unmanned aircraft. NovAtel fourth-quarter profit was relatively flat, as an increase in revenue was offset by higher costs. Jones Soda fourth-quarter profit more than tripled on strong sales and improved gross margins. Encysive Pharmaceuticals fourth-quarter loss widened as it spent money to launch its hypertension drug candidate Thelin.

 
Lumera Corp. (LMRA: chart), which makes polymer-based devices for the bioscience and electro-optics industries, widened its fourth-quarter losses to $3.13 million, or 17 cents per share, compared with $2.62 million, or 16 cents per share, in the year-ago period. Revenue climbed to $1.16 million versus $240,000 in the same period a year earlier.

AeroVironment Inc. (AVAV: chart), maker of unmanned aircraft systems, said that its third-quarter net profit increased to $8.89 million, or 57 cents per share, compared with $4.39 million, or 29 cents per share, in the year-ago period. Revenue climbed to $46.3 million against $35.5 million in the same period a year earlier.

NovAtel Inc. (NGPS: chart), maker of global positioning system receivers and components, reported fourth-quarter net income of C$5.14 million ($4.6 million) or 58 Canadian cents a share (52 cents), compared with C$5.13 million, or 58 Canadian cents a share, in the year-ago period. Revenues climbed to C$19.2 million versus C$16.2 million in the same period a year earlier.

Jones Soda Co. (JSDA: chart), natural soda maker, said that its fourth-quarter net earnings increased to $2.06 million, or 8 cents per share, compared with $580,245, or 3 cents per share, in the year-ago period. Revenue climbed to $10.05 million against $8.75 million in the same period a year ago.

Encysive Pharmaceuticals (ENCY: chart), drug developer, said fourth-quarter losses widened to $25.8 million, 44 cents a share, compared with $19.4 million, or 33 cents per share, a year earlier, due primarily to costs related to the launch of Thelin tablets in Europe and maintaining its commercial infrastructure in the U.S. Revenue declined to $5.4 million versus $5.6 million in the same period a year ago.
  1 More: Earnings Archive

 



 
© 1999-2008 123jump.com. All rights reserved